About this Journal Submit a Manuscript Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 185167, 13 pages
http://dx.doi.org/10.1155/2012/185167
Research Article

The Inhibition of Spinal Astrocytic JAK2-STAT3 Pathway Activation Correlates with the Analgesic Effects of Triptolide in the Rat Neuropathic Pain Model

1Department of Anatomy, Histology and Embryology and K. K. Leung Brain Research Centre, The Fourth Military Medical University, Xi'an 710032, China
2Department of Anesthesiology, School of Stomatology, The Fourth Military Medical University, Xi'an 710032, China
3Department of Neurosurgery, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China

Received 19 August 2012; Accepted 16 November 2012

Academic Editor: Mei Tian

Copyright © 2012 Jun Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Costigan, J. Scholz, and C. J. Woolf, “Neuropathic pain: a maladaptive response of the nervous system to damage,” Annual Review of Neuroscience, vol. 32, pp. 1–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. R. H. Dworkin, M. Backonja, M. C. Rowbotham et al., “Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations,” Archives of Neurology, vol. 60, no. 11, pp. 1524–1534, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. J. Gao and R. R. Ji, “Targeting astrocyte signaling for chronic pain,” Neurotherapeutics, vol. 7, no. 4, pp. 482–493, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. B. O'Connor and R. H. Dworkin, “Treatment of neuropathic pain: an overview of recent guidelines,” American Journal of Medicine, vol. 122, no. 10, supplement, pp. S22–S32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. L. R. Watkins, D. Martin, P. Ulrich, K. J. Tracey, and S. F. Maier, “Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat,” Pain, vol. 71, no. 3, pp. 225–235, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. E. D. Milligan, C. Twining, M. Chacur et al., “Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats,” The Journal of Neuroscience, vol. 23, no. 3, pp. 1026–1040, 2003. View at Scopus
  7. A. Meunier, A. Mauborgne, J. Masson, J. Mallet, and M. Pohl, “Lentiviral-mediated targeted transgene expression in dorsal spinal cord glia: tool for the study of glial cell implication in mechanisms underlying chronic pain development,” The Journal of Neuroscience Methods, vol. 167, no. 2, pp. 148–159, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. L. R. Watkins, E. D. Milligan, and S. F. Maier, “Glial activation: a driving force for pathological pain,” Trends in Neurosciences, vol. 24, no. 8, pp. 450–455, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. R. D. Fields and B. Stevens-Graham, “Neuroscience: new insights into neuron-glia communication,” Science, vol. 298, no. 5593, pp. 556–562, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. J. Gao and R. R. Ji, “Chemokines, neuronal-glial interactions, and central processing of neuropathic pain,” Pharmacology and Therapeutics, vol. 126, no. 1, pp. 56–68, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Tsuda, S. Beggs, M. W. Salter, and K. Inoue, “Micro and intractable chronic pain,” Glia, vol. 61, no. 1, pp. 55–61, 2012. View at Publisher · View at Google Scholar
  12. M. Zhuo, G. Wu, and L. J. Wu, “Neuronal and microglial mechanisms of neuropathic pain,” Molecular Brain, vol. 4, article 31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. X. P. Mei, H. Zhang, W. Wang et al., “Inhibition of spinal astrocytic c-Jun N-terminal kinase (JNK) activation correlates with the analgesic effects of ketamine in neuropathic pain,” Journal of Neuroinflammation, vol. 8, no. 1, article 6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. X. P. Mei, W. Wang, C. Zhu et al., “Combining ketamine with astrocytic inhibitor as a potential analgesic strategy for neuropathic pain. Ketamine, astrocytic inhibitor and pain,” Molecular Pain, vol. 6, article 50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Tsuda, Y. Kohro, T. Yano et al., “JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats,” Brain, vol. 134, no. 4, pp. 1127–1139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. E. Herrmann, T. Imura, B. Song et al., “STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury,” The Journal of Neuroscience, vol. 28, no. 28, pp. 7231–7243, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Dominguez, A. Mauborgne, J. Mallet, M. Desclaux, and M. Pohl, “SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury,” The Journal of Neuroscience, vol. 30, no. 16, pp. 5754–5766, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Dominguez, C. Rivat, B. Pommier, A. Mauborgne, and M. Pohl, “JAK/STAT3 pathway is activated in spinal cord microglia after peripheral nerve injury and contributes to neuropathic pain development in rat,” Journal of Neurochemistry, vol. 107, no. 1, pp. 50–60, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. E. Nicholson, D. de Souza, L. J. Fabri et al., “Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 12, pp. 6493–6498, 2000. View at Scopus
  20. L. Lu, F. Li, and X. Wang, “Novel anti-inflammatory and neuroprotective agents for Parkinson's disease,” CNS and Neurological Disorders—Drug Targets, vol. 9, no. 2, pp. 232–240, 2010. View at Scopus
  21. F. Q. Li, X. Z. Lu, X. B. Liang et al., “Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation,” Journal of Neuroimmunology, vol. 148, no. 1-2, pp. 24–31, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Han, M. Rostami-Yazdi, S. Gerdes, and U. Mrowietz, “Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases,” British Journal of Clinical Pharmacology, vol. 74, no. 3, pp. 424–436, 2012. View at Publisher · View at Google Scholar
  23. J. Cibere, Z. Deng, Y. Lin et al., “A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis,” Journal of Rheumatology, vol. 30, no. 3, pp. 465–467, 2003. View at Scopus
  24. Y. Gong, B. Xue, J. Jiao, L. Jing, and X. Wang, “Triptolide inhibits COX-2 expression and PGE2 release by suppressing the activity of NF-κB and JNK in LPS-treated microglia,” Journal of Neurochemistry, vol. 107, no. 3, pp. 779–788, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Xue, J. Jiao, L. Zhang et al., “Triptolide upregulates NGF synthesis in rat astrocyte cultures,” Neurochemical Research, vol. 32, no. 7, pp. 1113–1119, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. Z. Su, Y. Yuan, L. Cao et al., “Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation,” Glia, vol. 58, no. 8, pp. 901–915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Zimmermann, “Ethical guidelines for investigations of experimental pain in conscious animals,” Pain, vol. 16, no. 2, pp. 109–110, 1983. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Wang, X. P. Mei, Y. Y. Wei, et al., “Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain,” Brain, Behavior, and Immunity, vol. 25, no. 7, pp. 1355–1366, 2011. View at Publisher · View at Google Scholar
  29. R. V. Størkson, A. Kjørsvik, A. Tjølsen, and K. Hole, “Lumbar catheterization of the spinal subarachnoid space in the rat,” The Journal of Neuroscience Methods, vol. 65, no. 2, pp. 167–172, 1996. View at Publisher · View at Google Scholar · View at Scopus
  30. Q. Liu, T. Chen, G. Chen et al., “Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways,” Molecular Immunology, vol. 44, no. 10, pp. 2686–2696, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. R. J. Hamm, B. R. Pike, D. M. O'Dell, B. G. Lyeth, and L. W. Jenkins, “The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury,” Journal of Neurotrauma, vol. 11, no. 2, pp. 187–196, 1994. View at Scopus
  32. S. R. Chaplan, F. W. Bach, J. W. Pogrel, J. M. Chung, and T. L. Yaksh, “Quantitative assessment of tactile allodynia in the rat paw,” The Journal of Neuroscience Methods, vol. 53, no. 1, pp. 55–63, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. C. I. Svensson and E. Brodin, “Spinal astrocytes in pain processing: non-neuronal cells as therapeutic targets,” Molecular Interventions, vol. 10, no. 1, pp. 25–38, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Parpura, T. A. Basarsky, F. Liu, K. Jeftinija, S. Jeftinija, and P. G. Haydon, “Glutamate-mediated astrocyte-neuron signalling,” Nature, vol. 369, no. 6483, pp. 744–747, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Perea and A. Araque, “Astrocytes potentiate transmitter release at single hippocampal synapses,” Science, vol. 317, no. 5841, pp. 1083–1086, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Vallejo, D. M. Tilley, L. Vogel, and R. Benyamin, “The role of glia and the immune system in the development and maintenance of neuropathic pain,” Pain Practice, vol. 10, no. 3, pp. 167–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. X. D. Pan, X. C. Chen, Y. G. Zhu et al., “Tripchlorolide protects neuronal cells from microglia-mediated β-amyloid neurotoxicity through inhibiting NF-κB and JNK signaling,” Glia, vol. 57, no. 11, pp. 1227–1238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. H. F. Zhou, X. Y. Liu, D. B. Niu, F. Q. Li, Q. H. He, and X. M. Wang, “Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection,” Neurobiology of Disease, vol. 18, no. 3, pp. 441–449, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Jiao, B. Xue, L. Zhang et al., “Triptolide inhibits amyloid-β1-42-induced TNF-α and IL-1β production in cultured rat microglia,” Journal of Neuroimmunology, vol. 205, no. 1-2, pp. 32–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. F. He, W. Ge, K. Martinowich et al., “A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis,” Nature Neuroscience, vol. 8, no. 5, pp. 616–625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. C. L. Damiani and J. P. O'Callaghan, “Recapitulation of cell signaling events associated with astrogliosis using the brain slice preparation,” Journal of Neurochemistry, vol. 100, no. 3, pp. 720–726, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Yamauchi, K. Osuka, M. Takayasu et al., “Activation of JAK/STAT signalling in neurons following spinal cord injury in mice,” Journal of Neurochemistry, vol. 96, no. 4, pp. 1060–1070, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Kacimi, R. G. Giffard, and M. A. Yenari, “Endotoxin-activated microglia injure brain derived endothelial cells via NF-κB, JAK-STAT and JNK stress kinase pathways,” Journal of Inflammation, vol. 8, article 7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. S. Suzuki, K. Tanaka, S. Nogawa, T. Dembo, A. Kosakai, and Y. Fukuuchi, “Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats,” Experimental Neurology, vol. 170, no. 1, pp. 63–71, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. H. L. Lee, K. M. Lee, S. J. Son, S. H. Hwang, and H. J. Cho, “Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model,” NeuroReport, vol. 15, no. 18, pp. 2807–2811, 2004. View at Scopus
  46. G. Moalem and D. J. Tracey, “Immune and inflammatory mechanisms in neuropathic pain,” Brain Research Reviews, vol. 51, no. 2, pp. 240–264, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Oprée and M. Kress, “Involvement of the proinflammatory cytokines tumor necrosis factor-α, IL-1β, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin,” The Journal of Neuroscience, vol. 20, no. 16, pp. 6289–6293, 2000. View at Scopus
  48. J. T. Liou, F. C. Liu, C. C. Mao, Y. S. Lai, and Y. J. Day, “Inflammation confers dual effects on nociceptive processing in chronic neuropathic pain model,” Anesthesiology, vol. 114, no. 3, pp. 660–672, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. M. H. Cha, T. S. Nam, Y. Kwak, H. Lee, and B. H. Lee, “Changes in cytokine expression after electroacupuncture in neuropathic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 792765, 6 pages, 2012. View at Publisher · View at Google Scholar
  50. J. A. DeLeo, R. W. Colburn, M. Nichols, and A. Malhotra, “Interleukin-6-mediated hyperalgesia/allodynia and increased spinal IL-6 expression in a rat mononeuropathy model,” Journal of Interferon and Cytokine Research, vol. 16, no. 9, pp. 695–700, 1996. View at Scopus
  51. P. Dubový, I. Klusákov, I. Svíženská, and V. Brázda, “Satellite glial cells express IL-6 and corresponding signal-transducing receptors in the dorsal root ganglia of rat neuropathic pain model,” Neuron Glia Biology, vol. 6, no. 1, pp. 73–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. S. J. Geng, F. F. Liao, W. H. Dang et al., “Contribution of the spinal cord BDNF to the development of neuropathic pain by activation of the NR2B-containing NMDA receptors in rats with spinal nerve ligation,” Experimental Neurology, vol. 222, no. 2, pp. 256–266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. C. I. Svensson, X. Y. Hua, H. C. Powell, J. Lai, F. Porreca, and T. L. Yaksh, “Prostaglandin E2 release evoked by intrathecal dynorphin is dependent on spinal p38 mitogen activated protein kinase,” Neuropeptides, vol. 39, no. 5, pp. 485–494, 2005. View at Publisher · View at Google Scholar · View at Scopus
  54. W. Wang, W. Wang, X. Mei et al., “Crosstalk between spinal astrocytes and nuerons in nerve injury-injuced neuropathic pain,” PLoS ONE, vol. 4, no. 9, Article ID e6973, 2009. View at Publisher · View at Google Scholar · View at Scopus